glp 1 class drugs What to Make of the GLP-1 Coverage and Cost Landscape The Impact of GLP-1 Receptor

E., & Egan, J

This is thought to be mediated by direct GLP-1 receptor stimulation in the sinoatrial node

Biotechnology companies are subject to increased governmental regulation which may delay or inhibit the release of new products

This study also included an open-label comparator arm where participants took liraglutide 1.8 mg

Data shown as meanSD or percentage

This review addresses the promising landscape of GLP-1 RAs to treat persons with overweight or obesity, with or without T2DM, within the context of CKD, assessing their safety and impact on weight, metabolic control, blood pressure and kidney and cardiovascular outcomes, as part of a holistic patient-centred approach to preserve CKM health